- Home
- Mea At Home Testing Kits Market
MEA At-Home Testing Kits Market - Industry Trends and Forecast to 2029
- Published Date: September, 2022 | Report ID: CLS-536 | No of pages: 192 | Format:
The Middle East and Africa at-home testing kits market is projected to register a substantial CAGR of 4.5% in the forecast period of 2022 to 2029. The new market report contains data for the historic year 2020, the base year of calculation is 2021, and the forecast period is 2022 to 2029.
Market Segmentation
The Middle East and Africa At-Home Testing Kits Market, By Test Type (Pregnancy Test, HIV Test Kit, Diabetes, Infectious Diseases, Glucose Tests, Ovulation Predictor Test Kit, Drug Abuse Test Kit, and Others), Type (Cassette, Strip, Midstream, Test Panel, Dip Card, and Others), Age (Pediatric, Adult, and Geriatric), Sample Type (Urine, Blood, Saliva, and Others), Usage (Disposable and Reusable), Distribution Channels (Retail Pharmacies, Drug Store, Supermarket/Hypermarket, and Online Pharmacies), Country (South Africa, Saudi Arabia, U.A.E, Israel, Egypt, and Rest of Middle East and Africa) Industry Trends and Forecast to 2029
Some of the major factors contributing to the growth of the Middle East and Africa at-home testing kits market are:
Growing adoption of self-testing kits
Easy availability of self-testing kits at pharmacies
Increase in awareness about the importance of health diagnosis
Market Players
Some of the major players operating in the Middle East and Africa at-home testing kits market are:
Abbott, Siemens Healthcare GmbH
F. Hoffmann-La Roche Ltd
Drgerwerk AG & Co. KGaA
Ascensia Diabetes Care Holdings AG
Nectar Lifesciences Ltd.
ACON Laboratories
Quidel Corporation.
ARKRAY USA
BTNX INC.
Atomo Diagnostics
Eurofins Scientific
Piramal Enterprises Ltd.
Bionime Corporation
Nova Biomedical
Cardinal Health
OraSure Technologies
Everlywell
SA Scientific Ltd.
Clearblue
TABLE OF CONTENT
TABLE OF CONTENTS
1 INTRODUCTION 33
1.1 OBJECTIVES OF THE STUDY 33
1.2 MARKET DEFINITION 33
1.3 OVERVIEW OF MIDDLE EAST & AFRICA AT-HOME TESTING KITS MARKET 33
1.4 LIMITATIONS 35
1.5 MARKETS COVERED 35
2 MARKET SEGMENTATION 38
2.1 MARKETS COVERED 38
2.2 GEOGRAPHICAL SCOPE 39
2.3 YEARS CONSIDERED FOR THE STUDY 40
2.4 CURRENCY AND PRICING 40
2.5 DBMR TRIPOD DATA VALIDATION MODEL 41
2.6 MULTIVARIATE MODELLING 44
2.7 MIDDLE EAST & AFRICA AT-HOME TESTING KITS MARKET, BY TEST TYPE 44
2.8 MARKET POSITION COVERAGE GRID 45
2.9 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 46
2.10 DBMR MARKET POSITION GRID 47
2.11 DISTRIBUTOR CHANNEL ANALYSIS 48
2.12 SECONDARY SOURCES 49
2.13 ASSUMPTIONS 49
3 EXECUTIVE SUMMARY 50
4 PREMIUM INSIGHTS 53
4.1 PESTEL ANALYSIS 55
4.2 PORTER'S FIVE FORCES 56
5 MIDDLE EAST & AFRICA AT- HOME TESTING KITS MARKET: REGULATIONS 57
5.1 REGULATION IN U.S 57
5.2 GUIDELINES FOR SELF-TESTING KITS 57
5.3 REGULATION IN EUROPE 58
5.4 GUIDELINES FOR TESTING KITS 58
5.5 REGULATION IN INDONESIA: 58
6 MARKET OVERVIEW 60
6.1 DRIVERS 62
6.1.1 GROWING ADOPTION OF SELF-TESTING KITS 62
6.1.2 EASY AVAILABILITY OF SELF-TESTING KITS AT PHARMACIES 62
6.1.3 INCREASE IN AWARENESS ABOUT THE IMPORTANCE OF HIV DIAGNOSIS 62
6.1.4 EASE OF USE AND LOW COSTS OF RAPID SELF-TEST KITS 63
6.2 RESTRAINTS 63
6.2.1 INACCURACY OF RESULTS BY SELF-TESTING KITS 63
6.2.2 STRINGENT GOVERNMENT REGULATIONS FOR MANUFACTURING AND DISTRIBUTION OF TESTING KITS 64
6.3 OPPORTUNITIES 65
6.3.1 ADVENT OF ADVANCED TECHNOLOGIES 65
6.3.2 EMERGING NEED FOR RAPID TESTING KITS FOR COVID-19 PANDEMIC 65
6.3.3 STRATEGIC INITIATIVES OF KEY PLAYERS 66
6.4 CHALLENGES 66
6.4.1 HIGH COMPETITION IN THE MEDICAL TECHNOLOGY INDUSTRY 66
6.4.2 REDUCTION IN RESEARCH & DEVELOPMENT BUDGETS 67
7 MIDDLE EAST & AFRICA AT-HOME TESTING KITS MARKET, BY TEST TYPE 68
7.1 OVERVIEW 69
7.2 GLUCOSE TESTS 72
7.3 INFECTIOUS DISEASES 72
7.4 PREGNANCY TEST 73
7.5 DRUG ABUSE TEST KITS 74
7.6 HIV TEST KIT 75
7.7 OVULATION PREDICTOR TEST KIT 76
7.8 OTHERS TEST TYPES 76
8 MIDDLE EAST & AFRICA AT-HOME TESTING KITS MARKET, BY TYPE 78
8.1 OVERVIEW 79
8.2 CASSETTES 82
8.2.1 RETAIL PHARMACIES 83
8.2.2 ONLINE PHARMACIES 83
8.2.3 DRUG STORE 83
8.2.4 SUPERMARKET/HYPERMARKET 83
8.3 STRIP 83
8.3.1 RETAIL PHARMACIES 84
8.3.2 ONLINE PHARMACIES 84
8.3.3 DRUG STORE 84
8.3.4 SUPERMARKET/HYPERMARKET 84
8.4 MIDSTREAM 84
8.4.1 RETAIL PHARMACIES 85
8.4.2 ONLINE PHARMACIES 85
8.4.3 DRUG STORE 85
8.4.4 SUPERMARKET/HYPERMARKET 85
8.5 DIP CARD 86
8.5.1 RETAIL PHARMACIES 86
8.5.2 ONLINE PHARMACIES 87
8.5.3 DRUG STORE 87
8.5.4 SUPERMARKET/HYPERMARKET 87
8.6 TEST PANEL 87
8.6.1 RETAIL PHARMACIES 88
8.6.2 ONLINE PHARMACIES 88
8.6.3 DRUG STORE 88
8.6.4 SUPERMARKET/HYPERMARKET 88
8.7 OTHERS 88
9 MIDDLE EAST & AFRICA AT-HOME TESTING KITS MARKET, BY AGE 90
9.1 OVERVIEW 91
9.2 ADULT 94
9.3 GERIATRIC 94
9.4 PEDIATRIC 95
10 MIDDLE EAST & AFRICA AT-HOME TESTING KITS MARKET, BY SAMPLE TYPE 96
10.1 OVERVIEW 97
10.2 BLOOD 100
10.3 URINE 100
10.4 SALIVA 101
10.5 OTHER SAMPLE TYPES 101
11 MIDDLE EAST & AFRICA AT-HOME TESTING KITS MARKET, BY USAGE 103
11.1 OVERVIEW 104
11.2 DISPOSABLE 107
11.3 REUSABLE 107
12 MIDDLE EAST & AFRICA AT-HOME TESTING KITS MARKET, BY DISTRIBUTION CHANNELS 109
12.1 OVERVIEW 110
12.2 RETAIL PHARMACIES 113
12.3 ONLINE PHARMACIES 113
12.4 DRUG STORE 114
12.5 SUPERMARKET/HYPERMARKET 114
13 MIDDLE EAST & AFRICA AT-HOME TESTING KITS MARKET, BY REGION 116
13.1 MIDDLE EAST & AFRICA 117
13.1.1 SOUTH AFRICA 125
13.1.2 SAUDI ARABIA 128
13.1.3 U.A.E 131
13.1.4 ISRAEL 134
13.1.5 EGYPT 137
13.1.6 REST OF MIDDLE EAST & AFRICA 140
14 MIDDLE EAST & AFRICA AT-HOME TESTING KITS MARKET: COMPANY LANDSCAPE 141
14.1 COMPANY SHARE ANALYSIS: MIDDLE EAST & AFRICA 141
15 SWOT ANALYSIS 142
16 COMPANY PROFILE 143
16.1 ABBOTT 143
16.1.1 COMPANY SNAPSHOT 143
16.1.2 REVENUS ANALYSIS 143
16.1.3 COMPANY SHARE ANALYSIS 144
16.1.4 PRODUCT PORTFOLIO 144
16.1.5 RECENT DEVELOPMENT 144
16.2 SIEMENS HEALTHCARE GMBH 145
16.2.1 COMPANY SNAPSHOT 145
16.2.2 REVENUS ANALYSIS 145
16.2.3 PRODUCT PORTFOLIO 146
16.2.4 RECENT DEVELOPMENTS 146
16.3 F. HOFFMANN- LA ROCHE LTD 147
16.3.1 COMPANY SNAPSHOT 147
16.3.2 REVENUE ANALYSIS 147
16.3.3 COMPANY SHARE ANALYSIS 148
16.3.4 PRODUCT PORTFOLIO 148
16.3.5 RECENT DEVELOPMENTS 148
16.4 BD 149
16.4.1 COMPANY SNAPSHOT 149
16.4.2 REVENUE ANALYSIS 149
16.4.3 PRODUCT PORTFOLIO 150
16.4.4 RECENT DEVELOPMENTS 150
16.5 DRGERWERK AG & CO. KGAA 151
16.5.1 COMPANY SNAPSHOT 151
16.5.2 REVENUE ANALYSIS 151
16.5.3 COMPANY SHARE ANALYSIS 152
16.5.4 PRODUCT PORTFOLIO 152
16.5.5 RECENT DEVELOPMENTS 152
16.6 LIFESCAN IP HOLDINGS, LLC 153
16.6.1 COMPANY SNAPSHOT 153
16.6.2 COMPANY SHARE ANALYSIS 153
16.6.3 PRODUCT PORTFOLIO 154
16.6.4 RECENT DEVELOPMENTS 154
16.7 ASCENSIA DIABETES CARE HOLDINGS AG. 155
16.7.1 COMPANY SNAPSHOT 155
16.7.2 COMPANY SHARE ANALYSIS 155
16.7.3 PRODUCT PORTFOLIO 156
16.7.4 RECENT DEVELOPMENTS 156
16.8 NECTAR LIFESCIENCES LTD. (RAPIKIT) 157
16.8.1 COMPANY SNAPSHOT 157
16.8.2 PRODUCT PORTFOLIO 157
16.8.3 RECENT DEVELOPMENTS 157
16.9 ACON LABORATORIES, INC. 158
16.9.1 COMPANY SNAPSHOT 158
16.9.2 PRODUCT PORTFOLIO 158
16.9.3 RECENT DEVELOPMENTS 158
16.10 QUIDEL CORPORATION. 159
16.10.1 COMPANY SNAPSHOT 159
16.10.2 REVENUE ANALYSIS 159
16.10.3 PRODUCT PORTFOLIO 160
16.10.4 RECENT DEVELOPMENTS 160
16.11 ARKRAY USA, INC. 161
16.11.1 COMPANY SNAPSHOT 161
16.11.2 PRODUCT PORTFOLIO 161
16.11.3 RECENT DEVELOPMENTS 161
16.12 BTNX INC. 162
16.12.1 COMPANY SNAPSHOT 162
16.12.2 PRODUCT PORTFOLIO 162
16.12.3 RECENT DEVELOPMENTS 162
16.13 ATOMO DIAGNOSTICS 163
16.13.1 COMPANY SNAPSHOT 163
16.13.2 REVENUE ANALYSIS 163
16.13.3 PRODUCT PORTFOLIO 164
16.13.4 RECENT DEVELOPMENTS 164
16.14 EUROFINS SCIENTIFIC 165
16.14.1 COMPANY SNAPSHOT 165
16.14.2 REVENUE ANALYSIS 165
16.14.3 PRODUCT PORTFOLIO 166
16.14.4 RECENT DEVELOPMENTS 166
16.15 PIRAMAL ENTERPRISES LTD. 167
16.15.1 COMPANY SNAPSHOT 167
16.15.2 REVENUE ANALYSIS 167
16.15.3 PRODUCT PORTFOLIO 168
16.15.4 RECENT DEVELOPMENTS 168
16.16 BIONIME CORPORATION 169
16.16.1 COMPANY SNAPSHOT 169
16.16.2 REVENUE ANALYSIS 169
16.16.3 PRODUCT PORTFOLIO 170
16.16.4 RECENT DEVELOPMENTS 170
16.17 NOVA BIOMEDICAL 171
16.17.1 COMPANY SNAPSHOT 171
16.17.2 PRODUCT PORTFOLIO 171
16.17.3 RECENT DEVELOPMENTS 171
16.18 CARDINAL HEALTH. 172
16.18.1 COMPANY SNAPSHOT 172
16.18.2 REVENUE ANALYSIS 172
16.18.3 PRODUCT PORTFOLIO 173
16.18.4 RECENT DEVELOPMENTS 173
16.19 ORASURE TECHNOLOGIES 174
16.19.1 COMPANY SNAPSHOT 174
16.19.2 REVENUE ANALYSIS 174
16.19.3 PRODUCT PORTFOLIO 175
16.19.4 RECENT DEVELOPMENTS 175
16.20 BIOLYTICAL LABORATORIES INC. 176
16.20.1 COMPANY SNAPSHOT 176
16.20.2 PRODUCT PORTFOLIO 176
16.20.3 RECENT DEVELOPMENTS 176
16.21 EVERLYWELL, INC. 177
16.21.1 COMPANY SNAPSHOT 177
16.21.2 PRODUCT PORTFOLIO 177
16.21.3 RECENT DEVELOPMENTS 177
16.22 SA SCIENTIFIC LTD. 178
16.22.1 COMPANY SNAPSHOT 178
16.22.2 PRODUCT PORTFOLIO 178
16.22.3 RECENT DEVELOPMENTS 178
16.23 CLEARBLUE (A SUBSIDIARY OF SWISS PRECISION DIAGNOSTICS GMBH) 179
16.23.1 COMPANY SNAPSHOT 179
16.23.2 PRODUCT PORTFOLIO 179
16.23.3 RECENT DEVELOPMENTS 179
16.24 BIOSYNEX 180
16.24.1 COMPANY SNAPSHOT 180
16.24.2 PRODUCT PORTFOLIO 180
16.24.3 RECENT DEVELOPMENTS 180
16.25 PRIMA LAB SA 181
16.25.1 COMPANY SNAPSHOT 181
16.25.2 PRODUCT PORTFOLIO 181
16.25.3 RECENT DEVELOPMENTS 182
16.26 MP BIOMEDICALS. 183
16.26.1 COMPANY SNAPSHOT 183
16.26.2 PRODUCT PORTFOLIO 183
16.26.3 RECENT DEVELOPMENTS 183
16.27 STERILAB SERVICES 184
16.27.1 COMPANY SNAPSHOT 184
16.27.2 PRODUCT PORTFOLIO 184
16.27.3 RECENT DEVELOPMENTS 184
16.28 CHEMBIO DIAGNOSTICS, INC. 185
16.28.1 COMPANY SNAPSHOT 185
16.28.2 REVENUE ANALYSIS 185
16.28.3 PRODUCT PORTFOLIO 186
16.28.4 RECENT DEVELOPMENTS 186
16.29 BIOSURE 187
16.29.1 COMPANY SNAPSHOT 187
16.29.2 PRODUCT PORTFOLIO 187
16.29.3 RECENT DEVELOPMENTS 187
16.30 SELFDIAGNOSTICS OU 188
16.30.1 COMPANY SNAPSHOT 188
16.30.2 PRODUCT PORTFOLIO 188
16.30.3 RECENT DEVELOPMENTS 188
17 QUESTIONNAIRE 189
18 RELATED REPORTS 192
Segmentation
Short Description
Middle East and Africa At-Home Testing Kits Market, By Test Type (Pregnancy Test, HIV Test Kit, Diabetes, Infectious Diseases, Glucose Tests, Ovulation Predictor Test Kit, Drug Abuse Test Kit, and Others), Type (Cassette, Strip, Midstream, Test Panel, Dip Card, and Others), Age (Pediatric, Adult, and Geriatric), Sample Type (Urine, Blood, Saliva, and Others), Usage (Disposable and Reusable), Distribution Channels (Retail Pharmacies, Drug Store, Supermarket/Hypermarket, and Online Pharmacies), Country (U.S., Canada, Mexico, U.K., Germany, France, Spain, Italy, Netherlands, Switzerland, Russia, Belgium, Turkey, Rest of Europe, China, South Korea, Japan, India, Australia, Singapore, Malaysia, Indonesia, Thailand, Philippines, Rest of Asia-Pacific, South Africa, Saudi Arabia, U.A.E., Israel, Egypt, Rest of Middle East and Africa, Brazil, Argentina, Caribbean, Colombia, Peru, Chile, Panama, Venezuela, and Rest of South America) Industry Trends and Forecast to 2029
Market Definition
At-home testing kits means testing instruments which help people to perform tests at home and give them rapid results in a minute. It also includes health monitoring equipment to continuously check and control the health of the diabetic patient. At-home tests are very convenient to perform with comfort at home and are available at very affordable rate. Self-tests are usually the advance versions of rapid, point-of-care test kits that were originally designed for healthcare professionals and can be performed by common person. Their processes, packaging and instructions have been simplified so as to guide person through the steps of taking a test. Various at-home test kits are available including HIV test, pregnancy test, diabetes test, ovulation test, test for infectious diseases such as malaria, COVID-19, and others. For performing these rapid at-home tests, blood, urine, and oral fluid can be taken as a sample.
Market Segmentation:
The Middle East and Africa at-home testing kits market is categorized into six segments: test type, type, age, sample type, usage, and distribution channels.
On the basis of test type, the Middle East and Africa at-home testing kits market is segmented into pregnancy test, HIV test kit, diabetes, infectious diseases, glucose tests, ovulation predictor test kit, drug abuse test kit, and others
On the basis of type, the Middle East and Africa at-home testing kits market is segmented into cassette, strip, midstream, test panel, dip card, and others
On the basis of age, the Middle East and Africa at-home testing kits market is segmented into pediatric, adult, and geriatric
On the basis of sample type, the Middle East and Africa at-home testing kits market is segmented into urine, blood, saliva, and others
On the basis of usage, the Middle East and Africa at-home testing kits market is segmented into disposable and reusable
On the basis of distribution channels, the Middle East and Africa at-home testing kits market is segmented into retail pharmacies, drug store, supermarket/hypermarket, and online pharmacies
Market Players
The major companies which are dealing in the Middle East and Africa at-home testing kits market are listed below:
Abbott, Siemens Healthcare GmbH
F. Hoffmann La-Roche Ltd
Drgerwerk AG & Co. KGaA
LifeScan IP Holdings
Ascensia Diabetes Care Holdings AG
Nectar Lifesciences Ltd. (Rapikit)
ACON Laboratories, Inc.
Quidel Corporation.
ARKRAY USA, Inc.
BTNX INC.
Atomo Diagnostics
Eurofins Scientific
Piramal Enterprises Ltd.
Bionime Corporation
Nova Biomedical
Cardinal Health
OraSure Technologies, Inc.
BioLytical Laboratories Inc.
Everlywell, Inc.
SA Scientific Ltd.
Clearblue
Methodology
Get your pre and post sales queries resolved by our Subject matter experts.
We will assist you to customize the report to fit your research needs.
Our prime focus is to provide qualitative and accurate data.
Feel free to order a sample report before purchase.
Your personal and confidential information is safe and secured.
© 2025 Cognate Lifesciences. All Rights Reserved.